Why is Carlyle stock sliding today?
Carlyle Group (CG) stock fell 0.8% to $41.99 in pre-market trading after UBS downgraded it to Neutral, cutting its price target to $47 from $60. UBS cited reduced confidence in Carlyle's growth trajectory and ability to meet 2028 financial targets. Other analysts have also lowered price targets. The stock is below its 52-week high of $67.30 but above its low of $35.41.
How this was made
The 30-second read
Why it matters
The UBS downgrade is the primary catalyst for today's price slide, reinforcing concerns about fee‑related earnings growth.
Market read
CG's pre‑market decline reflects immediate market reaction to a fresh downgrade, offering a short‑term trading opportunity.
What to watch
Carlyle's recent fundraising ambition and strong earnings beat may cushion longer‑term performance despite the downgrade.
Background
Carlyle Group reported Q3 2026 earnings that beat estimates but left investors wary of near‑term growth, prompting analyst target revisions.
Ticker impact
UBS downgraded Carlyle Group to Neutral and cut its price target, causing the stock to slip 0.8% in pre‑market trading.
likely downward pressure as investors price in the lower target and reduced growth outlook
UBS is a major sell‑side analyst; its target cut and rating downgrade are new and directly linked to the observed pre‑market price decline.
Market effects
Alternative‑asset managers may see heightened scrutiny on fee growth expectations.
U.S. equity markets could see modest drag in the financial sector as the downgrade spreads.
Limited; the impact is primarily on U.S. listed alternative‑asset firms.
Counterpoint
If investors view the downgrade as over‑reacted, CG could rebound on short‑term buying interest.
Key entities
- CompanyCarlyle Group
Alternative asset manager listed on NYSE under ticker CG.
- AnalystUBS
Downgraded CG to Neutral and cut price target to $47.

